SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-19-000493
Filing Date
2019-08-12
Accepted
2019-08-12 17:29:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G DATED AUGUST 1, 2019 adamis13g-080119.htm SC 13G 72449
2 JOINT FILING AGREEMENT adamisex991-080119.htm EX-99.1 5881
  Complete submission text file 0001013594-19-000493.txt   79961
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45279 | Film No.: 191017587
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G